Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06640517
What this trial is testing

Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Biocad 140
Post-approval studies (Phase 4)Study completedNCT00967538
What this trial is testing

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Who this might be right for
Psoriasis
Innovaderm Research Inc. 89
Post-approval studies (Phase 4)Study completedNCT06032858
What this trial is testing

Efficacy and Safety of Apremilast in Psoriasis

Who this might be right for
Psoriasis
Ghurki Trust and Teaching Hospital 30
Not applicableStudy completedNCT01555606
What this trial is testing

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Janssen Biotech, Inc. 108
Large-scale testing (Phase 3)Study completedNCT02694523
What this trial is testing

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 684
Large-scale testing (Phase 3)Study completedNCT00570986
What this trial is testing

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 1,465
Large-scale testing (Phase 3)Study completedNCT01646073
What this trial is testing

Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 425
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Large-scale testing (Phase 3)UnknownNCT02701205
What this trial is testing

Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd 216
Large-scale testing (Phase 3)Study completedNCT03518047
What this trial is testing

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Who this might be right for
Psoriasis
AbbVie 50
Post-approval studies (Phase 4)Study completedNCT00512187
What this trial is testing

Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial

Who this might be right for
Chronic Plaque PsoriasisObesity
Universita di Verona
Testing effectiveness (Phase 2)Looking for participantsNCT06912165
What this trial is testing

WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Brief Description of Focus of Study
Zhejiang Wenda Pharma Technology LTD. 140
Post-approval studies (Phase 4)Study completedNCT05510063
What this trial is testing

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Samsung Bioepis Co., Ltd. 371
Testing effectiveness (Phase 2)Study completedNCT05268016
What this trial is testing

Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Meiji Pharma USA Inc. 132
Post-approval studies (Phase 4)WithdrawnNCT03146247
What this trial is testing

Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients

Who this might be right for
Moderate to Severe Plaque Psoriasis
Diamant Thaci
Large-scale testing (Phase 3)Study completedNCT03478787
What this trial is testing

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 327
Testing effectiveness (Phase 2)Study completedNCT05896527
What this trial is testing

Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 229
Post-approval studies (Phase 4)Study completedNCT05891964
What this trial is testing

Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.

Who this might be right for
Plaque Psoriasis
Jinnah Postgraduate Medical Centre 50
Post-approval studies (Phase 4)Study completedNCT03020199
What this trial is testing

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 196
Early research (Phase 1)Looking for participantsNCT06888193
What this trial is testing

Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL 20
Next Page